Wave Life Sciences (WVE) Interest Coverage Ratio (2014 - 2025)
Wave Life Sciences (WVE) posted Interest Coverage Ratio of 20.02 for Q4 2025, down 23833.17% on a QoQ basis from 0.08 in Q4 2024, and down 23833.17% year-over-year from N/an in Q4 2024.
Wave Life Sciences (WVE) Interest Coverage Ratio (2014 - 2025) Analysis & Trends
Wave Life Sciences' Interest Coverage Ratio history runs 12 years deep, the most recent figure standing at 20.02 for Q4 2025.
- Quarterly Interest Coverage Ratio fell 23833.17% year-over-year to 20.02 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 76.35 (down 18731.97% YoY) and the FY2025 annual result came in at 1.01, down 149.11% from the prior year.
- Interest Coverage Ratio was 20.02 for Q4 2025 at Wave Life Sciences, down from 0.08 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.08 in Q4 2024 and bottomed at 20.02 in Q4 2025.
- A 5-year average of 4.07 and a median of 0.15 in 2021 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2024 — Interest Coverage Ratio surged 211.6% — and 2025, when it sank 23833.17%.
- Wave Life Sciences' Interest Coverage Ratio stood at 0.15 in 2021, then declined by 26.98% to 0.19 in 2022, then jumped by 60.74% to 0.08 in 2023, then surged by 211.6% to 0.08 in 2024, then tumbled by 23833.17% to 20.02 in 2025.
- Business Quant data shows WVE's Interest Coverage Ratio at 20.02 in Q4 2025, 0.08 in Q4 2024, and 0.08 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -20.02 |
| Dec 31, 2024 | 0.08 |
| Dec 31, 2023 | -0.08 |
| Dec 31, 2022 | -0.19 |
| Dec 31, 2021 | -0.15 |
| Dec 31, 2020 | -0.16 |
| Dec 31, 2019 | -41.98 |
| Sep 30, 2019 | -1.19 |
| Jun 30, 2019 | -7.58 |
| Mar 31, 2019 | -34.28 |
| Dec 31, 2018 | -0.49 |
| Dec 31, 2017 | -0.86 |
| Dec 31, 2016 | -1.16 |
| Dec 31, 2015 | -0.97 |
| Sep 30, 2015 | -0.07 |
| Dec 31, 2014 | -0.67 |